These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Importance of secretory antibodies in nonsusceptibility to influenza B disease and the prevention of the spread of this virus]. Tsybul'skaia NV; Popova TL; Ispolatova AV; Tsybalova LM; Oleĭnikova EV Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):81-3. PubMed ID: 6226166 [TBL] [Abstract][Full Text] [Related]
5. [Interrelationships between serum and secretory antibodies in immunization with live influenza vaccine]. Shvartsman IaS; Krylov VA; Agranovskaia EN; Mal'tseva AI Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):35-8. PubMed ID: 128269 [TBL] [Abstract][Full Text] [Related]
6. [Secretory and serum response after intranasal influenza vaccination with A/Victoria attenuated live virus]. Crifò S; Filiaci F; Pelosio A; Rocchi G Boll Soc Ital Biol Sper; 1978 Jun; 54(11):1021-6. PubMed ID: 743410 [No Abstract] [Full Text] [Related]
7. [Secretory immunity of the nasal mucosa and its relevance to influenza]. Meyer P; Werner E Z Arztl Fortbild (Jena); 1985; 79(5):195-7. PubMed ID: 2408391 [No Abstract] [Full Text] [Related]
8. Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults. Fujimoto C; Takeda N; Matsunaga A; Sawada A; Tanaka T; Kimoto T; Shinahara W; Sawabuchi T; Yamaguchi M; Hayama M; Yanagawa H; Yano M; Kido H Influenza Other Respir Viruses; 2012 Nov; 6(6):396-403. PubMed ID: 22226319 [TBL] [Abstract][Full Text] [Related]
9. Assessment of resistance to influenza virus infection in animal models. Potter CW; McLaren C; Jennings R Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574 [TBL] [Abstract][Full Text] [Related]
10. The anamnestic response of the secretory immune system: A review. Rossen RD Dev Biol Stand; 1975; 28():224-36. PubMed ID: 165117 [TBL] [Abstract][Full Text] [Related]
11. Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines. Shvartsman YS; Agranovskaya EN; Zykov MP J Infect Dis; 1977 May; 135(5):697-705. PubMed ID: 858947 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine. Petrescu A; Steiner N; Trăilescu G; Teodosiu O; Mihăilescu M; Berca C Virologie; 1985; 36(3):187-94. PubMed ID: 4071977 [TBL] [Abstract][Full Text] [Related]
13. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines]. Sarateanu DE; Ehrengut W Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399 [No Abstract] [Full Text] [Related]
14. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain. Sidorova LA; Alekseyeva AK Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209 [No Abstract] [Full Text] [Related]
15. [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. Grigor'eva EP; Desheva IuA; Donina SA; Naĭkhin AN; Rekstin AR; Barantseva IB; Zavitkova EA; Moskvicheva TM; Zhavoronkov VG; Rudenko LG Vopr Virusol; 2002; 47(4):24-7. PubMed ID: 12271721 [TBL] [Abstract][Full Text] [Related]
16. Local SIgA response following administration of a novel intranasal inactivated influenza virus vaccine in community residing elderly. Muszkat M; Friedman G; Schein MH; Naveh P; Greenbaum E; Schlesinger M; Zakay-Rones Z; Yehuda AB Vaccine; 2000 Feb; 18(16):1696-9. PubMed ID: 10689151 [TBL] [Abstract][Full Text] [Related]
17. Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen. Mizuno D; Ide-Kurihara M; Ichinomiya T; Kubo I; Kido H J Immunol; 2006 Jan; 176(2):1122-30. PubMed ID: 16394001 [TBL] [Abstract][Full Text] [Related]
18. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine. Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461 [TBL] [Abstract][Full Text] [Related]
19. Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate. Ainai A; Suzuki T; Tamura SI; Hasegawa H Viral Immunol; 2017; 30(6):451-462. PubMed ID: 28650274 [TBL] [Abstract][Full Text] [Related]
20. Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys. Mizuno D; Kimoto T; Sakai S; Takahashi E; Kim H; Kido H Vaccine; 2016 Apr; 34(16):1881-8. PubMed ID: 26954466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]